MiRNA target enrichment analysis of co-expression network modules reveals important miRNAs and their roles in breast

Mohammad Javad Bazyari1, Seyed Hamid Aghaee-Bakhtiari2,1

  • 1Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, 37552 Mashhad University of Medical Sciences , Mashhad, Iran.

PubMed

Insights

This study identifies key microRNAs (miRNAs) involved in breast cancer progression using systems biology approaches. Researchers found hsa-mir-23b, hsa-let-7b, and hsa-mir-30a play crucial roles in this life-threatening cancer.

Area of Science:

  • Oncology
  • Genomics
  • Systems Biology

Background:

  • Breast cancer is a leading cause of cancer incidence and mortality.
  • Cancer progression is a critical factor in breast cancer's lethality.
  • MicroRNAs (miRNAs) are key regulators of gene expression influencing cancer properties, including progression.

Purpose of the Study:

  • To identify significant modules associated with breast cancer progression using weighted gene co-expression network analysis (WGCNA).
  • To discover critical miRNAs regulating breast cancer progression through target enrichment analysis.
  • To validate candidate miRNAs by examining their negative correlation with identified gene modules.

Main Methods:

  • Weighted Gene Co-expression Network Analysis (WGCNA) to identify gene modules related to breast cancer progression.
  • Hypergeometric test for miRNA target enrichment analysis.
  • Correlation analysis to link miRNA expression with module activity.

Main Results:

  • Identification of key gene modules significantly associated with breast cancer progression.
  • Discovery of specific miRNAs, including hsa-mir-23b, hsa-let-7b, and hsa-mir-30a, as important regulators.
  • Validation of these miRNAs through negative correlation with relevant gene modules.

Conclusions:

  • hsa-mir-23b, hsa-let-7b, and hsa-mir-30a are identified as significant miRNAs in breast cancer progression.
  • Systems biology approaches, particularly WGCNA, are effective for uncovering miRNA regulatory roles in cancer.
  • Further investigation into the roles of these miRNAs may offer new therapeutic strategies for breast cancer.